Efficacy and Safety of Lercanidipine and Valsartan in Patients With Essential Hypertension
Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of fixed combination of
lercanidipine (10 mg or 20 mg) and valsartan (80 mg or 160 mg), lercanidipine and valsartan
alone in reducing blood pressure. The study will investigate the dose response relationship
for the combinations and monotherapies.